Adjuvant therapy for resectable gastrointestinal stromal tumors: evidence, controversies, and practical guidance.

Shah A, John G, Mehta A, Ostwal V, Ramaswamy A, Bhargava P

Open source

DOI
10.1080/14737140.2026.2733840
Published
2026 Sep 17
Container
Expert review of anticancer therapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14737140.2026.2733840,
  title = {Adjuvant therapy for resectable gastrointestinal stromal tumors: evidence, controversies, and practical guidance.},
  author = {Shah A and John G and Mehta A and Ostwal V and Ramaswamy A and Bhargava P},
  year = {2026},
  journal = {Expert review of anticancer therapy},
  doi = {10.1080/14737140.2026.2733840},
  url = {https://doi.org/10.1080/14737140.2026.2733840}
}

RIS

TY  - JOUR
TI  - Adjuvant therapy for resectable gastrointestinal stromal tumors: evidence, controversies, and practical guidance.
AU  - Shah A
AU  - John G
AU  - Mehta A
AU  - Ostwal V
AU  - Ramaswamy A
AU  - Bhargava P
PY  - 2026
JO  - Expert review of anticancer therapy
DO  - 10.1080/14737140.2026.2733840
UR  - https://doi.org/10.1080/14737140.2026.2733840
ER  - 

APA

A, S., G, J., A, M., V, O., A, R., & P, B. (2026). Adjuvant therapy for resectable gastrointestinal stromal tumors: evidence, controversies, and practical guidance.. Expert review of anticancer therapy. https://doi.org/10.1080/14737140.2026.2733840

Source records